INGN-225: a dendritic cell-based p53 vaccine (Ad.p53-DC) in small cell lung cancer: observed association between immune response and enhanced chemotherapy effect-Reference-Cited by-同舟云学术

INGN-225: a dendritic cell-based p53 vaccine (Ad.p53-DC) in small cell lung cancer: observed association between immune response and enhanced chemotherapy effect

Published:2010-04-26 Issue:6 Volume:10 Page:983-991
ISSN:1471-2598
Container-title:Expert Opinion on Biological Therapy
language:en
Short-container-title:Expert Opinion on Biological Therapy

Author:

Chiappori Alberto A,Soliman Hatem,Janssen William E,Antonia Scott J,Gabrilovich Dmitry I

Publisher

Informa Healthcare

Subject

Clinical Biochemistry,Drug Discovery,Pharmacology

Link

http://www.tandfonline.com/doi/pdf/10.1517/14712598.2010.484801

Reference61 articles.

1. Cancer Statistics, 2008

2. Management of Small Cell Lung Cancer

3. Management of small cell lung cancer

4. Small Cell Lung Cancer*

5. Topotecan Versus Cyclophosphamide, Doxorubicin, and Vincristine for the Treatment of Recurrent Small-Cell Lung Cancer

Cited by 99 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Immunotherapy for small cell lung cancer: the current state and future trajectories;Discover Oncology;2024-08-16

2. Lung cancer vaccination from concept to reality: A critical review of clinical trials and latest advances;Life Sciences;2024-06

3. Neoantigen Identification and Dendritic Cell-Based Vaccines for Lung Cancer Immunotherapy;Vaccines;2024-05-05

4. Harnessing adenovirus in cancer immunotherapy: evoking cellular immunity and targeting delivery in cell-specific manner;Biomarker Research;2024-03-25

5. Cell fate regulation governed by p53: Friends or reversible foes in cancer therapy;Cancer Communications;2024-02-04